You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 15, 2026

Drug Price Trends for SOD SULFACET-SULFUR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SOD SULFACET-SULFUR

Average Pharmacy Cost for SOD SULFACET-SULFUR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SOD SULFACET-SULFUR 10-5% CLSR 58657-0472-08 0.48326 GM 2025-12-17
SOD SULFACET-SULFUR 10-5% CLSR 42192-0136-06 0.15504 GM 2025-12-17
SOD SULFACET-SULFUR 10-5% CLSR 42192-0136-08 0.48326 GM 2025-12-17
SOD SULFACET-SULFUR 10-5% CLSR 58657-0472-07 0.15504 GM 2025-12-17
SOD SULFACET-SULFUR 10-5% CLSR 42192-0136-12 0.14315 GM 2025-12-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for SOD SULFACET-SULFUR

Last updated: July 28, 2025

Introduction

SOD SULFACET-SULFUR, a topical medication combining sodium sulfacetamide and sulfur, is primarily utilized in the treatment of dermatological conditions such as acne, seborrheic dermatitis, and rosacea. Its dual antimicrobial and keratolytic action makes it a significant option within the OTC and prescription skincare markets. This analysis explores the current market landscape, competitive positioning, regulatory environment, and future price projections for SOD SULFACET-SULFUR.


Market Overview

Therapeutic and Market Demand

The dermatological segment, especially anti-acne and seborrheic dermatitis treatments, has witnessed consistent growth owing to rising prevalence rates and increased awareness of skin health. SOD SULFACET-SULFUR's therapeutic profile aligns well with the growing demand for effective, topical agents with antimicrobial and keratolytic properties.

According to a report by Market Research Future [1], the global acne treatment market alone was valued at approximately USD 4.9 billion in 2020, with a CAGR of around 4.3% projected through 2027. Such growth reflects a sustained need for antimicrobial agents like SOD SULFACET-SULFUR.

Market Penetration and Key Players

While SOD SULFACET-SULFUR is available through multiple manufacturers, its market penetration is influenced by factors such as formulation availability, pricing strategies, and physician prescribing habits. Major players include specialty dermatology companies and OTC brands, competing with alternatives like benzoyl peroxide, salicylic acid, and other sulfur-based formulations.

Distribution channels encompass dermatology clinics, pharmacies, online platforms, and OTC outlets, expanding accessibility for consumers.

Regulatory Landscape

SOD SULFACET-SULFUR formulations are generally regulated as over-the-counter (OTC) drugs in the U.S. and many international markets, facilitating broader consumer access. Regulatory agencies like the FDA have established monographs for sulfur and sulfacetamide products, streamlining approval procedures for topical formulations.

However, variations in regulations across countries influence market size and entry strategies, with some jurisdictions requiring prescription-only status for certain formulations due to safety or efficacy concerns.


Competitive Positioning

Product Differentiation

SOD SULFACET-SULFUR's competitive advantages include:

  • Dual-action efficacy: Combines antimicrobial activity with keratolytic effects.
  • Established safety profile: Long history of use with minimal systemic absorption.
  • Convenient topical application: Suitable for various dermatological conditions.

However, competition remains fierce from newer agents offering similar benefits with better cosmetic profiles, such as non-greasy formulations, or with reduced odor associated with sulfur compounds.

Market Challenges

  • Consumer preference shifting toward non-sulfur-based products.
  • Potential side effects like skin irritation or odor which can affect adherence.
  • Limited patent protection, leading to price erosion over time.

Key Competitive Brands

  • Acnotin (sulfur-based formulations)
  • Clearasil and similar OTC brands
  • Prescription options like erythromycin gel or clindamycin formulations

Pricing Landscape and Trends

Current Price Range

The retail price of SOD SULFACET-SULFUR products varies significantly based on formulation, brand, and region:

  • OTC formulations cost approximately USD 5–15 for a 60-gram tube.
  • Prescription formulations may range from USD 20–50 per month supply, depending on formulary arrangements and insurance coverage.

Pricing Influences

  • Brand positioning: Premium brands with proprietary formulations command higher prices.
  • Market segmentation: OTC products are generally more affordable to boost accessibility and volume sales.
  • Manufacturing costs: Fluctuations in raw material prices, especially sulfur, impact formulation costs.

Price Trends and Projections

Based on historical data and industry forecasts:

  • Moderate price erosion expected over the next 3–5 years due to market entry of generics and increasing competition.
  • Potential premium pricing for novel formulations offering improved cosmetic properties or reduced odor.
  • Impact of regulatory changes could influence pricing, especially if restrictions tighten on over-the-counter availability.

Future Market Drivers and Projections

Growth Factors

  • Rising dermatological conditions incidence: Increased awareness and diagnoses fuel demand.
  • Expansion into emerging markets: Growing middle-class populations and healthcare infrastructure development open new opportunities.
  • Product innovation: Formulations with better tolerability and aesthetic appeal permitted premium pricing.
  • Online sales channels: Increasing direct-to-consumer sales reduce distribution costs.

Price Projection Models

Considering current trends and potential market dynamics, the following projections are reasonable:

Year Estimated Price Range (USD) per unit Rationale
2023–2024 USD 6 – 12 Stable OTC pricing with minor erosion due to generics.
2025–2026 USD 5 – 10 Increasing generic competition, potential for price compression.
2027–2028 USD 4.5 – 9 Market maturation, commoditization, or incremental innovation.
2029+ USD 4 – 8 Potential price stabilization or driven by new formulations offering value-added benefits.

Regulatory and Market Impact on Pricing

Changes in regulatory environment, particularly around OTC classifications or safety warnings, could influence prices. For wholesale and retail markets, regulatory measures may:

  • Encourage formulary shifts towards alternative agents.
  • Lead to price adjustments based on safety updates.
  • Impact brand premiums and differential pricing strategies.

Advancements in delivery methods and formulation improvements (e.g., non-odor sulfur variants) may justify higher prices through perceived added value.


Key Takeaways

  • Growing Dermatological Demand: The increasing prevalence of skin conditions and consumer awareness contributes to steady demand for SOD SULFACET-SULFUR.
  • Competitive Dynamics: A mature market with significant OTC penetration and generic competition constrains pricing, trending towards lower margins.
  • Innovation and Differentiation: New formulations with enhanced cosmetic profiles could command premium prices, sustaining profitability.
  • Emerging Markets Opportunities: Expansion into developing regions presents potential for volume growth, albeit with price sensitivity.
  • Regulatory Factors: Changes in drug classification and safety warnings can significantly influence pricing strategies and market accessibility.

FAQs

1. What are the main competitors of SOD SULFACET-SULFUR in the dermatology market?
Competitors include other sulfur-based products, benzoyl peroxide, salicylic acid formulations, and newer agents like adapalene and tretinoin. OTC brands such as Clearasil also compete through alternative mechanisms.

2. How does regulation impact the pricing of SOD SULFACET-SULFUR?
Regulatory classification as OTC or prescription affects manufacturing costs, distribution channels, and profit margins. Stricter regulations or safety warnings could necessitate reformulation or repositioning, influencing prices.

3. What are the key factors that could increase the price of SOD SULFACET-SULFUR in the future?
Innovations offering better tolerability, reduced odor, or enhanced efficacy can justify higher prices. Additionally, entering premium segments in emerging markets or through online direct sales may also elevate pricing.

4. What role do generics play in the market for SOD SULFACET-SULFUR?
Generics exert downward pressure on prices, leading to erosion of margins for brand-name products. This promotes price competition but can also stimulate innovation to maintain market share.

5. Are there any regulatory risks that could significantly impact the market for SOD SULFACET-SULFUR?
Yes. Regulatory updates such as safety advisories or reclassification to prescription-only status could reduce accessibility and impact market volume, thereby affecting overall pricing strategies.


Sources

  1. Market Research Future. "Acne Treatment Market Analysis & Forecast (2020-2027)."
  2. U.S. Food and Drug Administration. Monograph on Topical Sulfur and Sulfacetamide Products.
  3. IQVIA. Dermatology Market Reports, 2022.
  4. GlobalData Healthcare. Skin Disorder Therapeutics Market Overview, 2022.
  5. Dermatology Business Reports. Trends in Topical Acne and Seborrheic Dermatitis Treatments, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.